Search research articles
Contact Us
Filters
Showing results (101-110 of 133) with videos related to
Page
of 14
Sort By:
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2017
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Benjamin M Ellingson, Elizabeth R Gerstner, Marion Smits, et al.
Nature Biomedical Engineering
|
April 6, 2019
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium
Giorgio Seano, Hadi T Nia, Kyrre E Emblem, et al.
Neuro-Oncology Advances
|
February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
Andrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma
Mary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.
Neuro-Oncology Advances
|
April 22, 2026
CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas
Shuodan Zhang, Byram H Ozer, Antonio Omuro, et al.
Neuro-Oncology
|
December 15, 2025
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular Immunotherapy
Eric P Grewal, Samuel J Steuart, Baolin Liu, et al.
Neuro-Oncology
|
April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors
Benjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2023
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma
Gilbert Youssef, Rifaquat Rahman, Camden Bay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2023
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients
K Ina Ly, Leland G Richardson, Mofei Liu, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 133) with videos related to
Sort By:
Page
of 14
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2017
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Benjamin M Ellingson, Elizabeth R Gerstner, Marion Smits, et al.
Nature Biomedical Engineering
|
April 6, 2019
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium
Giorgio Seano, Hadi T Nia, Kyrre E Emblem, et al.
Neuro-Oncology Advances
|
February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
Andrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma
Mary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.
Neuro-Oncology Advances
|
April 22, 2026
CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas
Shuodan Zhang, Byram H Ozer, Antonio Omuro, et al.
Neuro-Oncology
|
December 15, 2025
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular Immunotherapy
Eric P Grewal, Samuel J Steuart, Baolin Liu, et al.
Neuro-Oncology
|
April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors
Benjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 7, 2023
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma
Gilbert Youssef, Rifaquat Rahman, Camden Bay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2023
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients
K Ina Ly, Leland G Richardson, Mofei Liu, et al.
Page
of 14